专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20110166118A1 NEW TRINEM ANTIBIOTICS AND INHIBITORS OF BETA-LACTAMASES 审中-公开
标题翻译：新的TRINEM抗生素和β-Lactamases的抑制剂
公开(公告)号：US20110166118A1
公开(公告)日：2011-07-07
申请号：US12999078
申请日：2009-06-18
申请人： Ivan Plantan , Andrej Prezelj , Uros Urleb , Barbara Mohar , Michel Stephan
发明人： Ivan Plantan , Andrej Prezelj , Uros Urleb , Barbara Mohar , Michel Stephan
IPC分类号： A61K31/397 , C07D205/08 , C07D487/04 , A61P31/04
CPC分类号： C07D477/14
摘要： The present invention relates to a compound of Formula (I) in particular compounds of formula (Ia), the use of a therapeutically effective amount of one or more compounds of formula (I) or (Ia) as a broad-spectrum antibiotic and the use of a pharmaceutical composition comprising said compounds for the treatment of bacterial infections in humans or animals.
摘要翻译：本发明涉及式（I）化合物，特别是式（Ia）化合物，使用治疗有效量的一种或多种式（I）或（Ia）化合物作为广谱抗生素，使用包含所述化合物的药物组合物来治疗人或动物中的细菌感染。

2. 发明申请

US20090247516A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS 审中-公开
标题翻译： 3-（苯并[D] [1,3]二氧代-5-甲基乙基）-4-（THIO）OXO-2-（THIO）OXO-AZOLIDIN-5-YLIDENE DERIVATIVES作为抗菌剂
公开(公告)号：US20090247516A1
公开(公告)日：2009-10-01
申请号：US12442970
申请日：2007-10-08
申请人： Miha Kotnik , Marko Oblak , Petra Stefanic Anderluh , Andrej Prezelj , Jan Humljan , Ivan Plantan , Uros Urleb , Tomaz Solmajer
发明人： Miha Kotnik , Marko Oblak , Petra Stefanic Anderluh , Andrej Prezelj , Jan Humljan , Ivan Plantan , Uros Urleb , Tomaz Solmajer
IPC分类号： A61K31/5377 , C07D471/04 , A61K31/519 , C07D417/14 , A61K31/4439 , A61P31/04
CPC分类号： C07D471/04 , C07D417/06 , C07D417/14
摘要： The present invention concerns novel azolidine compounds of Formula (I) wherein X denotes S, NH, CH2 or O, Y and W denotes each independently S or O, Q denotes CH or N, n and m are an integer from 0 to 2, and R1 and R2 denote independently from each other hydrogen, optionally substituted aryl, optionally substituted heterocyclyl, or an optionally substituted (C1-10) aliphatic group, R3 denotes hydrogen, lower alkyl, halogen, lower alkoxy, nitro, and R4 and R5 denote independently from each other hydrogen, halogen or alkyl, with the proviso that if one of R1 and R2 is hydrogen then the respective other one of R1 and R2 does not denote substituted or unsubstituted 2-furyland their salts, that are useful as pharmaceutical agents, e.g. as antibacterial agents, and to pharmaceutical compositions comprising such compounds.
摘要翻译：本发明涉及式（I）的新的唑烷化合物，其中X表示S，NH，CH 2或O，Y和W各自独立地为S或O，Q表示CH或N，n和m为0至2的整数，并且R 1和R 2彼此独立地表示氢，任选取代的芳基，任选取代的杂环基或任选取代的（C 1-10）脂族基，R 3表示氢，低级烷基，卤素，低级烷氧基，硝基，R 4和R 5表示独立地为氢，卤素或烷基，条件是如果R 1和R 2之一为氢，则R 1和R 2中的相应另一个不表示可用作药剂的取代或未取代的2-呋喃基及其盐，例如作为抗菌剂，以及包含这些化合物的药物组合物。

3. 发明申请

US20110172200A1 USE OF INHIBITOR OF BETA-LACTAMASES AND ITS COMBINATION WITH BETA-LACTAM ANTIBIOTICS 审中-公开
标题翻译： β-LACTAMASES抑制剂的使用及其与BETA-LACTAM抗生素的组合
公开(公告)号：US20110172200A1
公开(公告)日：2011-07-14
申请号：US12864671
申请日：2009-01-28
申请人： Andrej Prezelj , Uros Urleb , Gregr Vilfan
发明人： Andrej Prezelj , Uros Urleb , Gregr Vilfan
IPC分类号： A61K31/43 , A61K31/397 , A61K31/546 , C07D477/12 , A61P31/04
CPC分类号： C07D477/00 , A61K31/397
摘要： The present invention relates to a pharmaceutical composition with broad-spectrum of activity against class A, class C and D enzymes comprising an antibiotic and a pharmaceutically effective amount of a compound of Formula (I), compounds of Formula (I), the use of a therapeutically effective amount of one or more compounds of Formula (I) as a broad-spectrum beta-lactamase inhibitor and the use of such a pharmaceutical composition for the treatment of an infection in humans or animals caused by bacteria.
摘要翻译：本发明涉及具有针对A类，C类和D类的广谱活性的药物组合物，其包含抗生素和药学有效量的式（I）化合物，式（I）化合物，使用治疗有效量的一种或多种式（I）化合物作为广谱β-内酰胺酶抑制剂，以及这种药物组合物用于治疗由细菌引起的人或动物感染的用途。

4. 发明申请

US20100029604A1 ANTIBACTERIAL COMBINATION AND ITS USE 审中-公开
标题翻译：抗菌组合及其使用
公开(公告)号：US20100029604A1
公开(公告)日：2010-02-04
申请号：US12525739
申请日：2008-02-13
申请人： Andrej Prezelj , Uros Urleb , Tomaz Solmajer
发明人： Andrej Prezelj , Uros Urleb , Tomaz Solmajer
IPC分类号： A61K31/431 , A61K31/407 , A61K31/546 , C07D477/12 , A61P31/04
CPC分类号： A61K31/43 , A61K31/403 , A61K31/427 , A61K31/496 , A61K31/545 , A61K31/546 , A61K2300/00
摘要： The invention relates to a pharmaceutical composition comprising an ethylene derivatives of tricyclic carbapenems of the general Formula (I) in the form of pure diastereoisomers and in the form of pure geometric isomers or a salt, ester or amide derivate thereof and an antibiotic and the use of this composition as a broad band spectrum β-lactamase inhibitor.
摘要翻译：本发明涉及一种药物组合物，其包含纯非对映异构体形式的通式（I）的三环碳青霉烯的乙烯衍生物和纯几何异构体的形式，或其盐，酯或酰胺衍生物和抗生素以及使用的该组合物作为宽带光谱β-内酰胺酶抑制剂。

5. 发明授权

US07632843B2 Treatment of psychostimulant addiction 失效
标题翻译：治疗精神兴奋剂成瘾
公开(公告)号：US07632843B2
公开(公告)日：2009-12-15
申请号：US10539501
申请日：2003-12-11
申请人： Igor Krisch , Marko Zivin , Natasa Milivojevic , Rudolf Rucman , Breda Bole-Vunduk , Uros Urleb
发明人： Igor Krisch , Marko Zivin , Natasa Milivojevic , Rudolf Rucman , Breda Bole-Vunduk , Uros Urleb
IPC分类号： A61K31/135 , A61K31/33 , A61K31/395 , A61K31/56 , A61P25/30
CPC分类号： A61K31/48 , Y10S514/81
摘要： The present invention belongs to the field of pharmaceutical industry and relates to a new method for the treatment of psychostimulant addiction, in particular cocaine addiction, or pharmaceutically acceptable acid addition salts thereof, with a therapeutically effective amount of 9,10-didehydro-N-methyl-N-(2-propy-nyl)-6-methyl-8β-aminomethylergo-line in the form of free base or in the form of pharmaceutically acceptable addition salt, in particular the bimaleate salt, as well as pharmaceutical compositions containing said compound. In literature, the compound is also known under code LEK-8829. More particularly, present invention relates to a novel method of treatment for reduction of abstinence symptoms after cocaine withdrawal and for suppression the symptoms of craving for cocaine withdrawal and for suppression the symptoms of craving for cocaine reinforcement, and to the use of said active substance for the preparation of the pharmaceutical composition for the treatment of cocaine addiction. In addition to the treatment of cocaine addiction, the present invention also relates to the method for treatment of the addiction with amphetamine, methamphetamine, dextroamphetamine, 3,4-methylenedioxymethamphetamine and pemoline or acid addition salts thereof.
摘要翻译：本发明属于制药工业领域，涉及一种用于治疗精神兴奋剂成瘾的新方法，特别是可卡因成瘾或其药学上可接受的酸加成盐，其具有治疗有效量的9,10-二脱氮-N- 甲基-N-（2-丙基）-6-甲基-β-氨基甲基麦角线，其形式为游离碱或药学上可接受的加成盐形式，特别是二马来酸盐，以及含有所述复合。在文献中，该化合物也以代号LEK-8829所知。更具体地，本发明涉及一种治疗可卡因戒断后禁欲症状的治疗方法，抑制可卡因戒断渴望症状，抑制可卡因加强渴求症状的新方法，以及所述活性物质用于制备用于治疗可卡因成瘾的药物组合物。除了治疗可卡因成瘾之外，本发明还涉及用苯丙胺，甲基苯丙胺，右旋安非他明，3,4-亚甲二氧基甲基安非他明和糠基苯甲酸或其酸加成盐治疗成瘾的方法。

6. 发明授权

US07285547B2 Amidinophenylalanine derivatives as thrombin inhibitors 失效
标题翻译：脒基苯丙氨酸衍生物作为凝血酶抑制剂
公开(公告)号：US07285547B2
公开(公告)日：2007-10-23
申请号：US10433358
申请日：2001-12-20
申请人： Uros Urleb , Anamarija Zega , Mojca Stegnar , Bakija Alenka Trampus , Tomaz Solmajer , Gregor Mlinsek
发明人： Uros Urleb , Anamarija Zega , Mojca Stegnar , Bakija Alenka Trampus , Tomaz Solmajer , Gregor Mlinsek
IPC分类号： A61P7/02 , A61K31/55 , C07D295/20
CPC分类号： C07D295/215 , C07C311/49
摘要： The compounds of the formula (formula 1) and pharmaceutically acceptable salts thereof and a process for preparing the same and pharmaceutical compositions containing the same are described wherein the substituents have the meaning as specified in the description. The compounds are used as thrombon inhibitors.
摘要翻译：描述了式（式1）化合物及其药学上可接受的盐及其制备方法和含有该化合物的药物组合物，其中取代基具有如说明书中所述的含义。化合物用作血栓抑制剂。

7. 发明授权

US5231216A Trans-2-acylaminocyclohexyloxyacyldipeptides in the form of mixtures of diastereoisomers thereof and in the form of pure diasteredisomers, process for the preparation thereof and pharmaceutical compositions containing the same 失效
标题翻译：转化-2-氨基甲酰氧基环己基二甲氧基硅烷在其二甲醚混合物形式及其制备方法中的用途及其含有药物组合物的方法
公开(公告)号：US5231216A
公开(公告)日：1993-07-27
申请号：US743233
申请日：1991-08-19
申请人： Slavko Pecar , Danijel Kikelj , Uros Urleb , Marija Sollner , Gasper Marc , Ales Krbavcic , Vlado Kotnik , Branka Wraber-Herzog , Sasa Simcie , Alojz Than , Lidija Klamfer , Lucka Povsic , Zdravko Kopitar , Anton Stalc
发明人： Slavko Pecar , Danijel Kikelj , Uros Urleb , Marija Sollner , Gasper Marc , Ales Krbavcic , Vlado Kotnik , Branka Wraber-Herzog , Sasa Simcie , Alojz Than , Lidija Klamfer , Lucka Povsic , Zdravko Kopitar , Anton Stalc
IPC分类号： C07K1/113 , A61K38/00 , C07C231/02 , C07C233/23 , C07C237/22 , C07D265/36 , C07K1/02 , C07K1/16 , C07K5/06 , C07K5/062
CPC分类号： C07K5/06026 , C07C233/23 , C07D265/36 , A61K38/00 , C07C2101/14
摘要： There are described novel trans-2-acylaminocyclohexyloxyacyldipeptides of formula I ##STR1## wherein R.sub.1 represents --CO--R.sub.6, --SO.sub.2 --R.sub.7 or ##STR2## R.sub.6 is C.sub.1 -C.sub.18 alkyl or C.sub.1 -C.sub.18 alkoxy, R.sub.7 is C.sub.1 -C.sub.18 alkyl or an optionally substituted phenyl group,Y is .dbd.O, .dbd.S or .dbd.NH;R.sub.2 =R.sub.3 and represent --H or C.sub.1 -C.sub.12 alkyl,R.sub.4 represents --OR.sub.8 or --NHR.sub.9,R.sub.8 is --H, C.sub.1 -C.sub.8 alkyl or benzyl,R.sub.9 is --H, a straight or branched chain C.sub.1 -C.sub.18 alkyl group or benzyl group;R.sub.5 represents --OR.sub.9 or --NHR.sub.9,and novel (1R,2R)- and (1S,2S)-trans-2-acylaminocyclohexyloxyacetyldipeptides of the formulas Ia and Ib ##STR3## wherein R.sub.1 is --CO--R.sub.6, R.sub.6 is C.sub.1 -C.sub.18 alkyl,R.sub.2 is --H,R.sub.3 is --H or C.sub.1 -C.sub.12 alkyl,R.sub.4 is --OR.sub.8 or --NHR.sub.9,R.sub.8 is --H, C.sub.1 -C.sub.8 alkyl or benzyl,R.sub.9 is --H, C.sub.1 -C.sub.18 alkyl or benzyl,R.sub.5 is --OR.sub.9 or --NHR.sub.9Compounds of formula I, Ia and Ib and the pharmaceutically acceptable alkali salts thereof show immunomodulatory and antitumour activities and can be used in the preparation of medicaments.

8. 发明申请

US20090234139A1 Novel Process 审中-公开
标题翻译：小说流程
公开(公告)号：US20090234139A1
公开(公告)日：2009-09-17
申请号：US11992212
申请日：2006-09-19
申请人： Lovro Selic , Gregor Vilfan , Uros Urleb
发明人： Lovro Selic , Gregor Vilfan , Uros Urleb
IPC分类号： C07D205/04
CPC分类号： C07F7/1892 , Y02P20/55
摘要： A novel process for the preparation of 1′-hydroxy-2′-substituted cyclohexyl azetidin-2-one compound of formula 2, which is important intermediate in the synthesis of trinems, is described by epoxide ring opening of (3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(1′R,2′S,3′R)-1′,2′-epoxycyclohexan-3′-yl]azetidin-2-one of formula 1 with the nucleophile compound of formula RYH, where nucleophile may act as solvent itself if the nucleophile is in the liquid form, in a suitable solvent and in the presence of a suitable catalyst from the group of salt of trifluoromethane sulfonic acid, preferably ytterbium (III) trifluoromethanesulfonate, stannous (II) trifluoromethanesulfonate or dysprosium (III) trifluoromethanesulfonate, under a) ultrasonic irradiation or b) under microwave irradiation of the reaction mixture following by isolation and purification of the desired compound. A variant of the novel process describes ring epoxide opening of the starting compound of formula 1 with the compound of formula NH4X in a suitable solvent under a) microwave irradiation or b) without microwave irradiation to obtain the desired compound of formula 2. Instead of compound of formula 1 a compound of formula 6 may be used as starting compound where any other suitable hydroxy protecting group known in the art may be used in the formula of the starting compound.
摘要翻译：（3S，4R） - 环糊精的环氧化物开环描述了制备式（2）的1'-羟基-2'-取代的环己基氮杂环丁烷-2-酮化合物的新方法，其是三聚氰胺合成中的重要中间体。 3 - [（1R）-1-（叔丁基二甲基甲硅烷氧基）乙基] -4 - [（1'R，2'S，3'R）-1'，2'-环氧环己烷-3'-基]氮杂环丁-2-酮式1与式RYH的亲核化合物反应，其中如果亲核试剂为液体形式，亲核试剂可以在合适的溶剂中和在三氟甲烷磺酸盐的合适的催化剂存在下，作为溶剂本身，优选（a）三氟甲磺酸镱（II），三氟甲磺酸亚锡（II），三氟甲磺酸镝（III），或b）在微波照射反应混合物之后，分离和纯化所需化合物。新方法的变体描述了式Ⅰ的起始化合物与式NH 4 X的化合物在合适的溶剂中在a）微波照射下或b）没有微波照射得到所需的式2化合物的环氧化物开环。代替化合物式1的化合物可以用作起始化合物，其中本领域已知的任何其它合适的羟基保护基可以用于起始化合物的式中。

9. 发明授权

US07553856B2 Crystalline form of omeprazole 有权
标题翻译：奥美拉唑的结晶形式
公开(公告)号：US07553856B2
公开(公告)日：2009-06-30
申请号：US11248461
申请日：2005-10-12
申请人： Natasa H Milac , Anton Copar , Barbara Podobnik , Andreja C Belcic , Alenka Kosak , Brina Ornik , Uros Urleb
发明人： Natasa H Milac , Anton Copar , Barbara Podobnik , Andreja C Belcic , Alenka Kosak , Brina Ornik , Uros Urleb
IPC分类号： A61K31/4439
CPC分类号： C07D401/12
摘要： A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.
摘要翻译：以化学名称为5-甲氧基-2 - [[（4-甲氧基-3,5-二甲基-2-吡啶基）甲基]亚磺酰基] -1H-苯并咪唑的新颖的底物结晶形式，具有通用名奥美拉唑，以下称为奥美曲唑C型。此外，公开了制备奥美拉唑C型的方法，一种含有与药学上可接受的赋形剂混合的奥美拉唑C形式的药物制剂以及奥美拉唑C型用于治疗胃肠道疾病的用途。

10. 发明申请

US20090018118A1 HETEROCYCLIC COMPOUNDS 审中-公开
标题翻译：杂环化合物
公开(公告)号：US20090018118A1
公开(公告)日：2009-01-15
申请号：US12159409
申请日：2006-12-27
申请人： Uros Urleb , Darko Kocjan , Tina Korosec , Damjana Rozman , Jure Acimovic , Alenka Tomazic , Breda Rode
发明人： Uros Urleb , Darko Kocjan , Tina Korosec , Damjana Rozman , Jure Acimovic , Alenka Tomazic , Breda Rode
IPC分类号： A61K31/551 , C07D401/14 , A61K31/496 , C07D401/06 , A61K31/5377 , C07D401/04
CPC分类号： C07D295/092 , C07D213/30 , C07D213/74 , C07D213/89 , C07D295/088
摘要： The invention is related to novel substituted diazaheterocycles useful as effective antihypercholesterolemic agents, methods of their preparation, and pharmaceutical compositions containing them.
摘要翻译：本发明涉及可用作有效抗高胆固醇血症药的新型取代的双氮杂环，其制备方法和含有它们的药物组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式